Jaime Merchan, MD, discusses the efficacy results observed in the LITESPARK-013 trial of belzutifan in patients with advanced clear cell renal cell carcinoma.

Before you plunk down hundreds of dollars for an infrared light device, know that the scientific evidence is not all in yet.

In an interview with Targeted Oncology, Jaime Merchan, MD, delved into data from the LITESPARK-013 trial evaluating ...

Adicet Bio has dosed the first subject in a multicentre Phase I trial of ADI-270, a gamma delta CAR T-cell therapy for treating ccRCC.

Analysis of genome-wide spatial transcriptomics data reveals cell-type specific subcellular RNA localization, and a subset of genes show significantly high correlation between spatial patterning and 3 ...

Thin-film solar cells are valued for their efficiency in material usage, requiring significantly less than traditional ...

Scientists have uncovered a new role for a cell's own RNA in fending off attacks by RNA viruses. Some of the cell's RNA ...

Long before home video cameras became popular, Austin’s Highland Mall offered shoppers a way to record holiday greetings that ...

Microbes found in green spaces can transfer into your body, increasing bacterial diversity and potentially boosting the ...

Study analyzed global patterns and trends in ovarian cancer incidence from 1988 to 2017, highlighting variations by ...

Many toys that will be opened by little ones during the holidays will need batteries to operate. But those batteries pose a ...